Welch Allyn recalls VS100 Spot Vision Screener software version 3.2.0.1 due to potential flickering that could trigger photosensitive seizures in susceptible individuals. Affected units sold with specific model and software version.
Display screen may unintentionally flicker due to a software issue. Exposure to flickering lights may induce photosensitive seizure activity in susceptible individuals.
Take action
Contact the company
📍Recalling firmBaxter Healthcare Corporation1 Baxter Pkwy · Deerfield, IL 60015-4625
“Welch Allyn Spot Vision Screener VS100: Flickering Screen May Trigger Seizures.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/49969-welch-allyn-spot-vision-screener-vs100-flickering-screen-may-trigger. Based on FDA recall #Z-1573-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1573-2026%22&limit=1).
The FDA announced on Feb. 18, 2026, that Baxter Healthcare Corporation is recalling Welch Allyn Spot Vision Screener VS100 devices due to a software issue causing the display screen to flicker. This hazard may induce photosensitive seizure activity in susceptible individuals.
The display screen may unintentionally flicker due to a software issue. Exposure to flickering lights may induce photosensitive seizure activity in susceptible individuals.
Context
GovInfoNow's records show Baxter Healthcare Corporation has 187 other recalls on record since Sept. 2, 2015. Other recent recalls include the Baxter Healthcare PRO+ 40" MRS SURFACE Mattress Recall (Aug. 18, 2026) and the Baxter 0.9% Sodium Chloride Injection Recall (Aug. 17, 2026).
How to tell if you have this one
Check if your device has software version 3.2.0.1. The product is sold under Welch Allyn, model VS100, with specific packaging details listed in the recall notice.
Brand
Welch Allyn
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Look for the software version on your device; affected units have version 3.2.0.1.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 14 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution in the states of AZ, CO, IL, IN, KS, MA, NE, NJ, NM, NY, PA, SC, TX, VA and the countries of Colombia and India.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Arizona, Colorado, Illinois, Indiana, Kansas, Massachusetts, Nebraska, New Jersey, New Mexico, New York, Pennsylvania, South Carolina, Texas, Virginia.
Recall timeline
FDA published this recall 35 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1573-2026 (February 18, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1573-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.